Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar;60(3):406-411.
doi: 10.1038/s41409-024-02487-w. Epub 2024 Dec 3.

Emapalumab for the Treatment of Immune-Mediated Graft Failure after HSCT

Pietro Merli  1 , Sonata Jodele  2   3 , Eleanor Cook  2   3 , Kasiani C Myers  2   3 , Adam Lane  2   3 , Samppa Ryhänen  4 , Maria Pia Cefalo  5 , Francesco Quagliarella  5 , Stella M Davies  2   3 , Ashley Teusink-Cross  3   6 , Paibel Aguayo-Hiraldo  7 , Jessie L Alexander  8 , Paul Szabolcs  8 , Mira Kohorst  9 , Tiziana Corsetti  10 , Franco Locatelli  5   11 , Anthony Sabulski  12   13
Affiliations

Emapalumab for the Treatment of Immune-Mediated Graft Failure after HSCT

Pietro Merli et al. Bone Marrow Transplant. 2025 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: PM, FL, JLA and AS have consulted for SOBI. SJ holds US Patent 10815 296 B2, “Methods of treatment of HSCT-associated thrombotic microangiopathy with eculizumab;” has received research support from Alexion Pharmaceuticals; and has had consultancies with Omeros, SOBI, and Alexion.

References

    1. Olsson RF, Logan BR, Chaudhury S, Zhu X, Akpek G, Bolwell BJ, et al. Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. Leukemia. 2015;29:1754–62. - DOI - PubMed - PMC
    1. Kharfan-Dabaja MA, Kumar A, Ayala E, Aljurf M, Nishihori T, Marsh R, et al. Standardizing definitions of hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the american society for transplantation and cellular therapy. Transpl Cell Ther. 2021;27:642–9. - DOI
    1. Merli P, Caruana I, De Vito R, Strocchio L, Weber G, Bufalo FD, et al. Role of interferon-gamma in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation. Haematologica. 2019;104:2314–23. - DOI - PubMed - PMC
    1. Sabulski A, Myers KC, Bleesing JJ, Duell A, Lane A, Teusink-Cross A, et al. Graft rejection markers in children undergoing hematopoietic cell transplant for bone marrow failure. Blood Adv. 2021;5:4594–604. - DOI - PubMed - PMC
    1. Rottman M, Soudais C, Vogt G, Renia L, Emile JF, Decaluwe H, et al. IFN-gamma mediates the rejection of haematopoietic stem cells in IFN-gammaR1-deficient hosts. PLoS Med. 2008;5:e26. - DOI - PubMed - PMC

LinkOut - more resources